Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) will release its earnings data after the market closes on Thursday, November 14th. Analysts expect Inovio Pharmaceuticals to post earnings of ($1.20) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Inovio Pharmaceuticals Stock Down 3.6 %
Inovio Pharmaceuticals stock opened at $5.34 on Tuesday. The company has a fifty day simple moving average of $5.88 and a 200-day simple moving average of $8.33. Inovio Pharmaceuticals has a 52-week low of $4.03 and a 52-week high of $14.75.
Analyst Ratings Changes
A number of research firms have commented on INO. Royal Bank of Canada cut their price objective on shares of Inovio Pharmaceuticals from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Friday, October 4th. Oppenheimer lowered their price objective on Inovio Pharmaceuticals from $40.00 to $33.00 and set an “outperform” rating on the stock in a research note on Monday, August 12th. Finally, HC Wainwright reaffirmed a “neutral” rating and issued a $15.00 target price on shares of Inovio Pharmaceuticals in a research note on Monday, July 15th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Inovio Pharmaceuticals presently has a consensus rating of “Hold” and an average price target of $43.80.
About Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.
Featured Articles
- Five stocks we like better than Inovio Pharmaceuticals
- What does consumer price index measure?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Does a Stock Split Mean?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Inovio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
